Replay available

CAMP4 Therapeutics Corporation (CAMP) Q2 2023 Earnings Call

CAMP4 Therapeutics Corporation (NASDAQ: CAMP) Q2 2023 earnings conference call, held 2022-09-22. Replay captured from the company's public earnings webcast.

Thu, September 22, 2022 at 5:00 PMendedReplay
CAMP4 Therapeutics Corporation (CAMP) Q2 2023 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Kurt Bender

Chief Financial Officer, CalAMP (Outgoing)

Mike Walke

Analyst, Canaccord

Jeff Gardner

President & CEO, CalAMP

Adam Bubis

Analyst, Goldman Sachs (on behalf of Jerry Revich)

Joel Akramowitz

Managing Director, Shelton Group

Blake Milkey

Analyst, Jefferies (on behalf of George Nodder)

Scott Searle

Analyst, Roth Capital

Mike Lattimore

Analyst, Northland Capital Markets

Replay transcript excerpt

Welcome to CalAMP's second quarter 2023 financial results conference call. My name is Tamia and I will be your moderator for today. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. If you would like to ask a question, please press star one on your telephone keypad. As a reminder, this call is being recorded. I would now like to introduce your host for today's conference call, Joel Akramovich, Managing Director of Shelton Group, CalAMP's investor relations firm. Joel, you may begin. Good afternoon and welcome to CalAMP's fiscal second quarter 2023 financial results conference call. I'm Joel Akramowitz, managing director of Shelton Group, CalAMP's investor relations firm. With us today are CalAMP's president and chief executive officer, Jeff Gardner, CFO Kurt Bender, and also Cindy Zhang, senior vice president of financial planning and analysis. Before we begin, I'd like to remind you that this call may contain forward-looking statements. While these forward-looking statements reflect CalAIM's best current judgment, they're subject to risks and uncertainties that could cause actual results to differ materially from those implied by these forward-looking projections. These risk factors are discussed in our regular SEC filings and in the earnings release issued today, which are available on our website. We undertake no obligation to revise or update any forward-looking statements to reflect future events or circumstances. Now, Jeff will begin today's call with a review of the company's operational highlights, and then Kurt will provide a more detailed review of the financial results, followed by a question and answer session. With that, it's my great pleasure to turn the call over to Calendars P...

More from Camp4 Therapeutics Corporation